Printer Friendly

Articles from MondayMorning (March 22, 2010)

1-26 out of 26 article(s)
Title Author Type Words
A noninvasive procedure that freezes and kills problem-causing heart tissue was nearly 10 times better at eliminating a potentially serious heart rhythm disorder than conventional anti-arrhythmic drugs, researchers said last week. 499
Abraxis Soars as cancer drug meets trial goal. Abraxis BioScience Inc. Brief article 276
An experimental blood thinner being developed by Merck & Co (Whitehouse Station NJ) from a new class of drugs appeared to be safe and effective in a mid-stage study that compared three doses against widely used warfarin in patients with atrial fibrillation. 322
Astellas submits OSI directors in hostile takeover bid. Astellas Pharma Inc. Brief article 291
Athenahealth Inc. Brief article 192
Biotechnology company CytRx Corp (Los Angeles CA) said its loss narrowed in 2009 as revenue increased and research and development costs fell. Brief article 242
Boston Scientific Corp. Brief article 304
British drugmaker AstraZeneca Plc said it has won the first trial brought by a patient alleging its psychiatric drug Seroquel caused harm. Brief article 277
Doctors are reporting an exciting win for gene testing and personalized medicine: Checking patients' DNA before starting them on a popular blood thinner helps get the tricky dose right and keep them out of the hospital. 369
Eli Lilly & Co. Brief article 236
FDA Roundup. 1073
In what appears to be a huge shift in clinical practice, women with suspected heart disease are being referred for cardiac catheterization twice as often as men, according to data presented at the 59th scientific sessions of the American College of Cardiology. Brief article 283
IPO sector: CorMedix Inc. Brief article 162
Markets: Stocks halted their steady climb Friday after renewed concerns about Greece's ability to pay its debts left investors questioning the prospects for a global economic recovery. Statistical data 388
Medical stock spotlight. 675
New research shows more patients who got drug-coated stents immediately after suffering a severe heart attack later died from heart-related problems than those who received older, cheaper bare-metal models. Brief article 310
Novartis AG. Brief article 293
Obama, Democrats on verge of healthcare votes. 583
Pfizer drops patent claim against Lilly over cialis. Pfizer Inc. Brief article 222
Roche to launch at least six new medicines by 2015. Roche Holding AG. 401
Teva to buy German generics drugmaker Ratiopharm for $5 Billion. 420
The leading drugmakers need to move quickly to adapt to a new world order in which some emerging markets are set to overtake some established national markets in pharmaceutical sales, according to a report issued last week. Brief article 304
Tracking Washington. Brief article 301
US safety panel says big Vytorin study can continue. Merck & Co. Brief article 296
Weekly Key Rates. Statistical table 110
Weekly Stock Performance. Statistical table 454

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters